All News #Library
Rare Diseases
Ipsen completes acquisition of Albireo, expanding the scope of Rare Disease
02 Mar 2023 //
GLOBENEWSWIRE
Failed deal, bidding war paved the way for Ipsen`s $952M rare disease buyout
24 Jan 2023 //
ENDPTS
Ipsen to Acquire Albireo Accelerating Growth in Rare Disease
09 Jan 2023 //
BUSINESSWIRE
Liver-focused startup nabs $115M in exchange for rare disease drug royalties
26 Sep 2022 //
ENDPTS

Market Place
Sourcing Support